Ascendis Pharma A (ASND) Divestments (2014 - 2026)

Ascendis Pharma A has disclosed Divestments across 13 years of filings, most recently posting -$7.9 million for Q1 2026.

• Divestments for Q1 2026 came in at -$7.9 million, down 969.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.8 million (down 1532.97% YoY), and the FY2025 annual result was -$9.9 million, down 234.11% from the prior year.
• Divestments came in at -$7.9 million for Q1 2026 at Ascendis Pharma A, down from -$3.9 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $226.1 million in Q1 2023 to a low of -$7.9 million in Q1 2026.
• The 5-year median for Divestments is $654747.6 (2024), against an average of $21.6 million.
• Across the five-year window, Divestments jumped 3448.29% in 2023 and sank 969.14% in 2026, its largest moves.
• Ascendis Pharma A's Divestments stood at $233636.6 in 2022, then surged by 3448.29% to $8.3 million in 2023, then slumped by 104.74% to -$393243.1 in 2024, then plunged by 903.77% to -$3.9 million in 2025, then slumped by 100.29% to -$7.9 million in 2026.
• The last three Divestments figures came in at -$7.9 million (Q1 2026), -$3.9 million (Q4 2025), and -$61959.9 (Q3 2025), per Business Quant data.